Back to School: How biopharma can reboot drug development. Access exclusive analysis here

MGI 114 (6-HMAF) alkylating agent that alters DNA: Update

MGI Pharma Inc. (MOGN), Minneapolis, Minn.
Product: MGI

Read the full 82 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE